These findings, in addition to demonstrating the resistance of engineered melanoma model cell lines to MEK and BRAF inhibitors in a 3D tissue culture system, clearly highlight the value of the 3D tissue culture format for the screening and optimization of novel chemotherapeutics and combination drug therapies for the treatment of drug-resistant melanomas. This evidence concerns the gene BRAF and melanoma.